Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Ophthalmology
Published in: BMC Ophthalmology 1/2024

Open Access 01-12-2024 | Xanthogranuloma | Research

Clinicopathological study of ophthalmic cutaneous and mucocutaneous non-langerhans cell histiocytic lesions

Authors: Hind Manaa Alkatan, Dalal R. Fatani, Azza M.Y. Maktabi, Tariq A. Alzahem

Published in: BMC Ophthalmology | Issue 1/2024

Login to get access

Abstract

Background

The “C group” of the histiocytic disorders is characterized by non-Langerhans-cell histiocytic lesions in the skin, mucosal surfaces, or both, out of which Juvenile xanthogranuloma (JXG) is the most common typically affecting the skin. The eye is the most common extra-cutaneous site of JXG., we aim at providing our clinical and histopathological experience with this group of diseases including the adult-onset xanthogranuloma (AXG).

Methods

This is a retrospective cohort study of all patients with the tissue diagnosis of ocular and periocular cutaneous and mucocutaneous non-LCH disorders who presented to us over a period of 25 years (January 1993 to December 2018).

Results

Twenty patients were diagnosed as “Group C” disease with an age range of 2 months-60.9 years. Eleven patients were females (55%) and nine were males (45%). The involvement was mostly unilateral in 80.9%. All cases fell into the xanthogranuloma family with 11 JXG patients, 8 AXG patients of skin and ocular surface, and one patient with solitary reticulohistiocytoma (SRH). The clinical site of involvement in JXG was primarily in the eyelid in 5 patients (45%), ocular surface lesions in 2 (18%), iris in 2 (18%), choroidal and bilateral orbital lesions in 1 patient each (9%). The group of AXG, presented equally with eyelid lesions in 4/8 and ocular surface lesions in 4/8. The non-Langerhans’ histiocytic infiltrate showed supportive immunohistochemical staining properties (reactive to CD68 marker and negative to S-100 and langerin markers).

Conclusion

Among the rare histiocytic disorders, xanthogranulomatosis is the commonest and has wide clinical manifestations. Accurate diagnosis needs to be supported by typical histopathological findings. JXG was the commonest in our study with relatively older mean age at presentation and frequent eyelid rather than iris involvement. AXG is often confused with xanthelasma when involving the eyelids with corneal limbal involvement is relatively frequent.
Literature
1.
Lichtenstein L, Histiocytosis X. Integration of eosinophilic granuloma of bone, letterer-siwe disease, and Schüller-Christian disease as related manifestations of a single nosologic entity. AMA Arch Pathol. 1953;56(1):84–102.PubMed
2.
3.
Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127(22):2672–81.PubMedPubMedCentralCrossRef
4.
Hernandez-Martin A, Baselga E, Drolet BA, Esterly NB. Juvenile xanthogranuloma. J Am Acad Dermatol. 1997;36(3 Pt 1):355–67. quiz 68–9.PubMedCrossRef
5.
Freyer DR, Kennedy R, Bostrom BC, Kohut G, Dehner LP. Juvenile xanthogranuloma: forms of systemic disease and their clinical implications. J Pediatr. 1996;129(2):227–37.PubMedCrossRef
6.
Orsey A, Paessler M, Lange BJ, Nichols KE. Central nervous system juvenile xanthogranuloma with malignant transformation. Pediatr Blood Cancer. 2008;50(4):927–30.PubMedCrossRef
7.
Karcioglu ZA, Mullaney PB. Diagnosis and management of iris juvenile xanthogranuloma. J Pediatr Ophthalmol Strabismus. 1997;34(1):44–51.PubMedCrossRef
8.
9.
Derzko-Dzulynsky L. IgG4-related disease in the eye and ocular adnexa. Curr Opin Ophthalmol. 2017;28(6):617–22.PubMedCrossRef
10.
Ebbo M, Patient M, Grados A, Groh M, Desblaches J, Hachulla E, et al. Ophthalmic manifestations in IgG4-related disease: clinical presentation and response to treatment in a French case-series. Med (Baltim). 2017;96(10):e6205.CrossRef
11.
Dehner LP. Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol. 2003;27(5):579–93.PubMedCrossRef
12.
Alkatan HM, Al-Rajhi AA. Corneal xanthogranuloma in association with multiple endocrine neoplasia 1: a clinicopathologic case report and review of the literature. Saudi J Ophthalmol. 2016;30(1):49–52.PubMedCrossRef
13.
Weitzman S, Jaffe R. Uncommon histiocytic disorders: the non-langerhans cell histiocytoses. Pediatr Blood Cancer. 2005;45(3):256–64.PubMedCrossRef
14.
Janssen D, Harms D. Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry. Am J Surg Pathol. 2005;29(1):21–8.PubMedCrossRef
15.
Chang MW, Frieden IJ, Good W. The risk intraocular juvenile xanthogranuloma: survey of current practices and assessment of risk. J Am Acad Dermatol. 1996;34(3):445–9.PubMedCrossRef
16.
Sanders TE. Intraocular juvenile xanthogranuloma (nevoxanthogranuloma): a survey of 20 cases. Trans Am Ophthalmol Soc. 1960;58:59–74.PubMedPubMedCentral
17.
Zimmerman LE. Ocular lesions of juvenile xanthogranuloma. Nevoxanthoedothelioma. Am J Ophthalmol. 1965;60(6):1011–35.PubMedCrossRef
18.
DeBarge LR, Chan CC, Greenberg SC, McLean IW, Yannuzzi LA, Nussenblatt RB. Chorioretinal, iris, and ciliary body infiltration by juvenile xanthogranuloma masquerading as uveitis. Surv Ophthalmol. 1994;39(1):65–71.PubMedCrossRef
19.
Wertz FD, Zimmerman LE, McKeown CA, Croxatto JO, Whitmore PV, LaPiana FG. Juvenile xanthogranuloma of the optic nerve, disc, retina, and choroid. Ophthalmology. 1982;89(12):1331–5.PubMedCrossRef
20.
Hildebrand GD, Timms C, Thompson DA, Atherton DJ, Malone M, Levitt G, et al. Juvenile xanthogranuloma with presumed involvement of the optic disc and retina. Arch Ophthalmol. 2004;122(10):1551–5.PubMedCrossRef
21.
Johnson TE, Alabiad C, Wei L, Davis JA. Extensive juvenile xanthogranuloma involving the orbit, sinuses, brain, and subtemporal fossa in a newborn. Ophthal Plast Reconstr Surg. 2010;26(2):133–4.PubMedCrossRef
22.
Hayashi N, Komatsu T, Komatsu T, Hiroi M, Ueno H. Juvenile xanthogranuloma presenting with unilateral prominent nodule of the eyelid: report of a case and clinicopathological findings. Jpn J Ophthalmol. 2004;48(5):435–9.PubMedCrossRef
23.
Kuruvilla R, Escaravage GK Jr., Finn AJ, Dutton JJ. Infiltrative subcutaneous juvenile xanthogranuloma of the eyelid in a neonate. Ophthal Plast Reconstr Surg. 2009;25(4):330–2.PubMedCrossRef
24.
Mocan MC, Bozkurt B, Orhan D, Kuzey G, Irkec M. Juvenile xanthogranuloma of the corneal limbus: report of two cases and review of the literature. Cornea. 2008;27(6):739–42.PubMedCrossRef
25.
Blank H, Eglick PG, Beerman H. Nevoxantho-Endothelioma with ocular involvement. Pediatrics. 1949;4(3):349–54.PubMedCrossRef
26.
Samara WA, Khoo CT, Say EA, Saktanasate J, Eagle RC Jr., Shields JA, et al. Juvenile Xanthogranuloma involving the eye and ocular adnexa: tumor control, visual outcomes, and globe salvage in 30 patients. Ophthalmology. 2015;122(10):2130–8.PubMedCrossRef
27.
Cambiaghi S, Restano L, Caputo R. Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies. Pediatr Dermatol. 2004;21(2):97–101.PubMedCrossRef
28.
Ferrari F, Masurel A, Olivier-Faivre L, Vabres P. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1. JAMA Dermatology. 2014;150(1):42–6.PubMedCrossRef
29.
Fenot M, Stalder JF, Barbarot S. Juvenile xanthogranulomas are highly prevalent but transient in young children with neurofibromatosis type 1. J Am Acad Dermatol. 2014;71(2):389–90.PubMedCrossRef
30.
Raygada M, Arthur DC, Wayne AS, Rennert OM, Toretsky JA, Stratakis CA. Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia. Pediatr Blood Cancer. 2010;54(1):173–5.PubMedPubMedCentralCrossRef
31.
Shin HT, Harris MB, Orlow SJ. Juvenile myelomonocytic leukemia presenting with features of hemophagocytic lymphohistiocytosis in association with neurofibromatosis and juvenile xanthogranulomas. J Pediatr Hematol Oncol. 2004;26(9):591–5.PubMedCrossRef
32.
Pantalon A, Stefanache T, Danciu M, Zurac S, Chiselita D. Iris juvenile xanthogranuloma in an infant - spontaneous hyphema and secondary glaucoma. Romanian J Ophthalmol. 2017;61(3):229–36.CrossRef
33.
Parmley VC, George DP, Fannin LA. Juvenile xanthogranuloma of the iris in an adult. Arch Ophthalmol. 1998;116(3):377–9.PubMedCrossRef
34.
35.
36.
Kaur H, Cameron JD, Mohney BG. Severe astigmatic amblyopia secondary to subcutaneous juvenile xanthogranuloma of the eyelid. J AAPOS: Official Publication Am Association Pediatr Ophthalmol Strabismus. 2006;10(3):277–8.CrossRef
37.
Shields CL, Shields JA, Buchanon HW. Solitary orbital involvement with juvenile xanthogranuloma. Arch Ophthalmol. 1990;108(11):1587–9.PubMedCrossRef
38.
Lee KM, Wee WR, Lee JH, Kim MK. Juvenile xanthogranuloma presenting as infiltrative conjunctival mass in an adult. Cornea. 2012;31(4):447–9.PubMedCrossRef
39.
De Keyser C, Maudgal P, Legius E, Van Ginderdeuren R, Casteels I. Juvenile xanthogranuloma of the corneoscleral limbus: report of two cases. Ophthalmic Genet. 2011;32(1):54–6.PubMedCrossRef
40.
Rad AS, Kheradvar A. Juvenile xanthogranuloma: concurrent involvement of skin and eye. Cornea. 2001;20(7):760–2.PubMedCrossRef
41.
Harley RD, Romayananda N, Chan GH. Juvenile xanthogranuloma. J Pediatr Ophthalmol Strabismus. 1982;19(1):33–9.PubMedCrossRef
42.
Fischbach J, Sause W. Radiation therapy in the management of ocular juvenile xanthogranuloma. Int J Radiat Oncol Biol Phys. 1982;8(5):959–60.PubMedCrossRef
43.
Ashkenazy N, Henry CR, Abbey AM, McKeown CA, Berrocal AM, Murray TG. Successful treatment of juvenile xanthogranuloma using bevacizumab. J AAPOS: Official Publication Am Association Pediatr Ophthalmol Strabismus. 2014;18(3):295–7.CrossRef
44.
Casteels I, Olver J, Malone M, Taylor D. Early treatment of juvenile xanthogranuloma of the iris with subconjunctival steroids. Br J Ophthalmol. 1993;77(1):57–60.PubMedPubMedCentralCrossRef
45.
Cleasby GW. Nevoxanthoendothelioma (juvenile xanthogranuloma) of the iris. Diagnosis by biopsy and treatment with x-ray. Arch Ophthalmol. 1961;66:26–8.PubMedCrossRef
46.
Jakobiec FA, Mills MD, Hidayat AA, Dallow RL, Townsend DJ, Brinker EA, et al. Periocular xanthogranulomas associated with severe adult-onset asthma. Trans Am Ophthalmol Soc. 1993;91:99–125. discussion – 9.
47.
Sivak-Callcott JA, Rootman J, Rasmussen SL, Nugent RA, White VA, Paridaens D, et al. Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review. Br J Ophthalmol. 2006;90(5):602–8.PubMedPubMedCentralCrossRef
48.
Chiou CC, Wang PN, Yang LC, Kuo TT, Hong HS. Disseminated xanthogranulomas associated with adult T-cell leukaemia/lymphoma: a case report and review the association of haematologic malignancies. J Eur Acad Dermatology Venereology: JEADV. 2007;21(4):532–5.CrossRef
49.
Chang SE, Cho S, Choi JC, Choi JH, Sung KJ, Moon KC, et al. Clinicohistopathologic comparison of adult type and juvenile type xanthogranulomas in Korea. J Dermatol. 2001;28(8):413–8.PubMedCrossRef
50.
Kerstetter J, Wang J. Adult orbital xanthogranulomatous disease: a review with emphasis on etiology, systemic associations, diagnostic tools, and treatment. Dermatol Clin. 2015;33(3):457–63.PubMedCrossRef
51.
52.
53.
54.
Wang JJ, Edward DP, Tu E. Xanthogranuloma of the corneoscleral limbus in an adult. Can J Ophthalmol. 2001;36(5):275–7.PubMedCrossRef
55.
Mohamed SR, Matthews N, Calcagni A. Juvenile Xanthogranuloma of the Limbus in an adult. JAMA Ophthalmol. 2002;120(7):976–7.
56.
Kobayashi A, Shirao Y, Takata Y, Wajima R, Nonomura A, Huang AJ. Adult-onset limbal juvenile xanthogranuloma. Arch Ophthalmol. 2002;120(1):96–7.PubMedCrossRef
57.
Hirata M, Nozaki M, Ozeki H, Hirata F, Ogura Y. A case of adult limbal xanthogranuloma. Jpn J Ophthalmol. 2007;51(4):302–4.PubMedCrossRef
58.
Soler V, Capuani C, Arne JL, Malecaze F, Fournie P. Juvenile xanthogranuloma of the corneoscleral limbus. J Fr Ophtalmol. 2009;32(6):e4361–6.
59.
Hermel M, Donner A, Remky A. New treatment option for adult-onset limbal xanthogranuloma. Cornea. 2010;29(1):113–6.PubMedCrossRef
60.
Callejo SA, Coupland SE, Damato B. Limbal juvenile xanthogranuloma in an adult. JAMA Ophthalmol. 2011;129(5):676.
61.
Castro-Gomez M, Villena-Irigoyen O, Caballero-Gonzalez S, Vergara Alcaide E. Juvenile xanthogranuloma of the corneoscleral limbus in adults. Arch De La Sociedad Esp De Oftalmologia. 2014;89(6):242–4.CrossRef
62.
Kontos GT, Coupland SE, Quah SA. A case of a limbal adult onset xanthogranuloma. Acta Ophthalmol. 2014;92(8):e692–3.PubMedCrossRef
63.
Kiratli H, Kilic M, Tarlan B, Soylemezoglu F. Adult orbital xanthogranulomas: clinical features and management. Eur J Ophthalmol. 2015;25(4):288–92.PubMedCrossRef
64.
Davies MJ, Whitehead K, Quagliotto G, Wood D, Patheja RS, Sullivan TJ. Adult orbital and adnexal xanthogranulomatous disease. Asia-Pacific J Ophthalmol (Philadelphia Pa). 2017;6(5):435–43.
65.
Chiang E, Lissner G, Bryar PJ. Unusual presentation of xanthogranuloma on the eyelid of an adult. Ophthal Plast Reconstr Surg. 2014;30(6):e155–6.PubMedCrossRef
66.
Dosari S, Hussain H, Maktabi A, Alkatan H, Alkatan M. Journal of clinical case studies open access periocular adult-onset xanthogranuloma (AOX) initially misdiagnosed as xanthelasma: a case report. J Clin Case Stud. 2016;1.
67.
Lim ILZ, Li L. Juvenile xanthogranuloma of the corneoscleral limbus. Cornea. 2005;24(6):745–7.CrossRef
68.
Kontos G, Borooah S, Khan A, Fleck BW, Coupland SE. The epidemiology, clinical characteristics, histopathology and management of juvenile- and adult-onset corneoscleral limbus xanthogranuloma. Graefes Arch Clin Exp Ophthalmol. 2016;254(3):413–20.PubMedCrossRef
69.
Brem C, Tang B, Silverman J, Bunker M. 212 IgG4-positive plasma cells in adult orbital xanthogranulomatous disease without IgG4-related disease: a series of two cases. Am J Clin Pathol. 2018;149(suppl1):S90–1.CrossRef
70.
Hayden A, Wilson DJ, Rosenbaum JT. Management of orbital xanthogranuloma with methotrexate. Br J Ophthalmol. 2007;91(4):434–6.PubMedCrossRef
71.
Elner VM, Mintz R, Demirci H, Hassan AS. Local corticosteroid treatment of eyelid and orbital xanthogranuloma. Trans Am Ophthalmol Soc. 2005;103:69–73. discussion – 4.
72.
Murthy R, Honavar SG, Vemuganti GK, Naik M, Burman S. Isolated giant xanthogranuloma of the orbit. Indian J Ophthalmol. 2007;55(2):156–8.PubMedCrossRef
73.
Karcioglu ZA, Sharara N, Boles TL, Nasr AM. Orbital xanthogranuloma: clinical and morphologic features in eight patients. Ophthalmic Plast Reconstr Surg. 2003;19(5):372–81.PubMedCrossRef
74.
Satchi K, McNab AA, Godfrey T, Prince HM. Adult orbital xanthogranuloma successfully treated with rituximab. Ophthalmology. 2014;121(8):1664-5.e1–3.
75.
Alzahem T, Maktabi A, Alkatan H. Solitary reticulohistiocytoma: a rare ocular surface mass. Can J Ophthalmol. 2021;56(2):e64–6.PubMedCrossRef
Metadata
Title
Clinicopathological study of ophthalmic cutaneous and mucocutaneous non-langerhans cell histiocytic lesions
Authors
Hind Manaa Alkatan
Dalal R. Fatani
Azza M.Y. Maktabi
Tariq A. Alzahem
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Xanthogranuloma
Published in
BMC Ophthalmology / Issue 1/2024
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-024-03388-8

Other articles of this Issue 1/2024

BMC Ophthalmology 1/2024 Go to the issue

Research

The effect of polyethylene cover intervention on ocular surface disorder of intensive care unit patients: a systematic review and meta-analysis

Case Report

Swept-source optical coherence tomography angiography findings in a case of primary vitreoretinal lymphoma over a three-year follow-up

Research

Comparison of intravitreal preservative-free triamcinolone versus posterior sub-tenon triamcinolone acetonide injection for bevacizumab-resistant diabetic macular edema

Research

Childhood glaucoma profile in a Southwestern Ethiopia tertiary care center: a retrospective study

Research

Factors affecting anophthalmic socket reconstruction outcomes using autologous oral mucosal graft

Case Report

Frosted branch angiitis in a patient with systemic juvenile idiopathic arthritis: a case report